Multicenter analysis of survival and prognostic factors in pathologic stage i non-small-cell lung cancer according to the new 2009 TNM classification;Análisis multicéntrico de supervivencia y factores pronósticos en el carcinoma no microcítico de pulmón en estadio I patológico según la nueva clasificación TNM de 2009

Archivos de Bronconeumologia

Volumn 47, Issue 9, 2011, Pages 441-446

  León Atance, Pablo ^a   Moreno Mata, Nicolás ^b   González Aragoneses, Federico ^c   Cañizares Carretero, Miguel Ángel ^d   García Jiménez, María Dolores ^a   Genovés Crespo, Marta ^a   Honguero Martínez, Antonio Francisco ^a   Rombolá, Carlos Alberto ^a   Simón Adiego, Carlos María ^c   Peñalver Pascual, Rafael ^c  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d Sección de Cirugía Torácica   (Spain)

Author keywords

Non small cell lung cancer; Pathologic stage; Prognostic factors; Survival

Indexed keywords

AGED; AGING; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

EID: 80052437914     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2011.04.006     Document Type: Article

References (29)

1. Youlden D.R., Cramb S.M., Baade P.D. The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J Thorac Oncol 2008, 3:819-831.
2. Sánchez de Cos Escuin J.S. El cáncer de pulmón en España. Epidemiología, supervivencia y tratamiento actuales. Arch Bronconeumol 2009, 45:341-348.
3. Goldstraw P. International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology 2009, Editorial Rx Press, Orange Park.
4. Detterbeck F.C., Boffa D.J., Tanoue L.T. The new lung cancer staging system. Chest 2009, 136:260-271.
5. Scott W.J., Howington J., Feigenberg S., Movsas B., Pisters K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:234S-242S.
6. Verdecchia A., Francisci S., Brenner H., Gatta G., Micheli A., Mangone L., et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007, 8:784-796.
7. Berrino F., De Angelis R., Sant M., Rosso S., Bielska-Lasota M., Coebergh J.W., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007, 8:773-783.
8. Tsuboi M., Ohira T., Saji H., Miyajima K., Kajiwara N., Uchida O., et al. The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2007, 13:73-77.
9. Buccheri G., Ferrigno D. Prognostic factors in lung cancer: tables and comments. Eur Respir J 1994, 7:1350-1364.
10. Brundage M.D., Davies D., Mackillop W.J. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002, 122:1037-1057.
11. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706-714.
12. Rami-Porta R., Ball D., Crowley J., Giroux D.J., Jett J., Travis W.D., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602.
13. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 1997, 111:1710-1717.
14. Rusch V.W., Asamura H., Watanabe H., Giroux D.J., Rami-Porta R., Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:568-577.
15. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ. 1995;311:899-909.
16. Visbal A.L., Leighl N.B., Feld R., Shepherd F.A. Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer. Chest 2005, 128:2933-2943.
17. Scagliotti G. Multimodality approach to early-stage non-small cell lung cancer. Lung Cancer 2007, 57(Suppl 2):S6-S11.
18. Suehisa H., Toyooka S. Adjuvant chemotherapy for completely resected non-small-cell lung cancer. Acta Med Okayama 2009, 63:223-230.
19. Chansky K., Sculier J.P., Crowley J.J., Giroux D., Van Meerbeeck J., Goldstraw P. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009, 4:792-801.
20. Lopez-Encuentra A., Duque-Medina J.L., Rami-Porta R., De la Camara A.G., Ferrando P. Staging in lung cancer: is 3cm a prognostic threshold in pathologic stage I non-small cell lung cancer? A multicenter study of 1,020 patients. Chest 2002, 121:1515-1520.
21. Salvatierra Velázquez A. Nueva estadificación TNM del cáncer de pulmón. Rev Esp Patol Torac 2010, 22:263-271.
22. Beasley M.B., Brambilla E., Travis W.D. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005, 40:90-97.
23. Travis W.D., Garg K., Franklin W.A., Wistuba I.I., Sabloff B., Noguchi M., et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol 2006, 1:S13-S19.
24. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60:615-622.
25. Nakamura H., Kawasaki N., Taguchi M., Kabasawa K. Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis. Br J Cancer 2005, 92:1033-1037.
26. Nakayama H., Yamada K., Saito H., Oshita F., Ito H., Kameda Y., et al. Sublobar resection for patients with peripheral small adenocarcinomas of the lung: surgical outcome is associated with features on computed tomographic imaging. Ann Thorac Surg 2007, 84:1675-1679.
27. Sugi K., Kobayashi S., Sudou M., Sakano H., Matsuda E., Okabe K. Long-term prognosis of video-assisted limited surgery for early lung cancer. Eur J Cardiothorac Surg 2010, 37:456-460.
28. Chamogeorgakis T., Ieromonachos C., Georgiannakis E., Mallios D. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?. Interact Cardiovasc Thorac Surg 2009, 8:364-372.
29. Arenberg D. Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:306S-313S.